Correlation Between Cumulus Media and Esperion Therapeutics

Can any of the company-specific risk be diversified away by investing in both Cumulus Media and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumulus Media and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cumulus Media Class and Esperion Therapeutics, you can compare the effects of market volatilities on Cumulus Media and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumulus Media with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumulus Media and Esperion Therapeutics.

Diversification Opportunities for Cumulus Media and Esperion Therapeutics

-0.8

Correlation Coefficient

Cumulus Media  Esperion Therapeutics

Pay attention - limited upside

The 3 months correlation between Cumulus and Esperion is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Cumulus Media Class and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Cumulus Media is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumulus Media Class are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Cumulus Media i.e., Cumulus Media and Esperion Therapeutics go up and down completely randomly.

Pair Corralation between Cumulus Media and Esperion Therapeutics

Given the investment horizon of 90 days Cumulus Media Class is expected to under-perform the Esperion Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cumulus Media Class is 1.05 times less risky than Esperion Therapeutics. The stock trades about -0.22 of its potential returns per unit of risk. The Esperion Therapeutics is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  172.00  in Esperion Therapeutics on September 5, 2024 and sell it today you would earn a total of  153.00  from holding Esperion Therapeutics or generate 88.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Cumulus Media Class  vs.  Esperion Therapeutics

Cumulus Media Class

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cumulus Media Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Esperion Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cumulus Media and Esperion Therapeutics

The main advantage of trading using opposite Cumulus Media and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumulus Media position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.

The idea behind Cumulus Media Class and Esperion Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.